Drug Pricing in the US

Drug Pricing in the US

  • August 2017 •
  • Report ID: 5168621 •
  • Format: PDF
Drug prices in the US have been the subject of intense debate over the past 2–3 years, following a surge in spending on prescription medicines and steep price increases in some categories. Public support for government action to curb prices is widespread. President Donald Trump has vowed to intervene, and the federal government is expected to unveil pricing reform proposals during the second half of 2017.

n the meantime, state legislatures are debating a slew of bills designed to address prescription drug prices and curb pharmaceutical spending, while in the private sector, other stakeholders are keen to exert more control over a pricing agenda that is currently dominated by manufacturers and pharmacy benefit managers.